To evaluate the in vivo dynamics of LAIR-1–mediated suppression of leukemic cell growth, we used a cell-derived xenograft (CDX) model of AML allowing for mechanistic studies that cannot be readily performed in PDX models. Here, LAIR1 is linked to acute myeloid leukemia.